Piper Sandler Assumes Ionis Pharmaceuticals (IONS) at Overweight, 'we think shares can work to the $58/sh range'
Tweet Send to a Friend
(Updated - June 7, 2023 4:14 AM EDT)
Piper Sandler analyst Allison Bratzel assumes coverage on Ionis Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Allison Bratzel assumes coverage on Ionis Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
